Trial intelligence / Profile preview

Salvianolic acid A sodium for myocardial protection after PCI in acute STEMI

CTR20213269Phase 2Completed

Sponsor
Bencao Tianyuan
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of salvianolic acid a in myocardial infarction (MI), acute coronary syndrome (ACS), sponsored by Bencao Tianyuan. Started Dec 2021; status: completed.

02

Drugs

salvianolic acid a
03

Conditions

myocardial infarction (MI)acute coronary syndrome (ACS)

Beyond the preview

Go deeper on CTR20213269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20213269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call